Jim Slattery

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 4

Top Topics

Machine Learning

Emergency Department

Top Venues

Pharmacoepidemiology and drug safety

European Medicines Agency

This page only lists publications with an associated author ORCID identifier.

Affiliation History

European Medicines Agency Aug 16 2004

Netherlands

Statistician :: Surveillance and Epidemiology

Publications

Andrej Segec, Jim Slattery, Daniel R Morales, Justina Januskiene, Xavier Kurz, Peter Arlett
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data. Pharmacoepidemiology and drug safety 30 (3) (2020)
Justina Januskiene, Andrej Segec, Jim Slattery, Georgy Genov, Kelly Plueschke, Xavier Kurz, Peter Arlett
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring? Pharmacoepidemiology and drug safety 30 (3) (2020)
Jim Slattery, Xavier Kurz
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness? Pharmacoepidemiology and drug safety 29 (10) (2020)
Jacoline C Bouvy, Kevin Blake, Jim Slattery, Marie Louise De Bruin, Peter Arlett, Xavier Kurz
Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013. Pharmacoepidemiology and drug safety 26 (12) (2017)